Similar articles

• Cancer chemotherapy and the development of secondary leukemia.

  Abe T, Misawa S. Abe T, et al. Nihon Ketsueki Gakkai Zasshi. 1985 Dec;48(8):1843-56. Nihon Ketsueki Gakkai Zasshi. 1985. PMID: 3836550 No abstract available.
• [Carcinogenicity of anticancer agents].

  Hayashi Y, Takahashi M, Yoshimura H. Hayashi Y, et al. Gan To Kagaku Ryoho. 1990 Dec;17(12):2293-8. Gan To Kagaku Ryoho. 1990. PMID: 2260866 Review. Japanese.
• Erythroleukemia in the adjuvant treatment of breast cancer.

  Lichtman SM, Schulman P, Budman DR. Lichtman SM, et al. N Y State J Med. 1985 Oct;85(10):601-3. N Y State J Med. 1985. PMID: 3866166 No abstract available.
• [Development of second tumors in patients with Hodgkin's disease (review of the literature and personal data)].

  Kanaev SV, Kholin AV, Gershanovich ML, Malinin AP. Kanaev SV, et al. Vopr Onkol. 1987;33(5):11-8. Vopr Onkol. 1987. PMID: 3590664 Russian.
• Carcinogenic effects of chemotherapeutic compounds.

  Klein-Szanto AJ. Klein-Szanto AJ. Prog Clin Biol Res. 1992;374:167-74. Prog Clin Biol Res. 1992. PMID: 1620702 Review. No abstract available.